India To Use Dexamethasone For Moderate To Severe Cases

The Union Health Ministry has updated its clinical management protocols for COVID-19 to include Dexamethasone as an alternative to methylprednisolone for moderate and severe cases. 

Dexamethasone, a corticosteroid will be used on patients requiring oxygen support. This drug showed positive results in the clinical trials conducted by RECOVERY Trials in UK. It reduced mortality by one-third in ventilated patients. 

Update: 2020-06-27 08:31 GMT

Linked news